您的位置: 首页 > 农业专利 > 详情页

GLUCAGON DERIVATIVES
专利权人:
LTD.;HANMI PHARM CO.
发明人:
Sung Youb JUNG,Young Jin PARK,Jong Suk LEE,Jae Hyuk CHOI,Chang Ki LIM,Se Chang KWON
申请号:
US16684110
公开号:
US20200140515A1
申请日:
2019.11.14
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention relates to a novel peptide of a glucagon derivative and a composition for preventing or treating obesity comprising the peptide as an active ingredient. The glucagon derivative according to the present invention shows a more excellent activating effect with regard to both glucagon-like peptide-1 receptors and glucagon receptors compared to native glucagon, and thus can be widely used as an effective agent for treating obesity.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充